Distributed by

AMGEN MANUFACTURING LIMITED

Featured products of Amgen

Kanjinti

Kanjinti powd for conc for soln for infusion 150 mg

trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Mvasi

Mvasi infusion conc 100 mg/4 mL

bevacizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Mvasi infusion conc 400 mg/16 mL

bevacizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Neulastim

Neulastim soln for inj 6 mg/0.6 mL

pegfilgrastim

Packing/Price

(pre-filled syringe) 1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Neupogen

Neupogen soln for inj 300 mcg/mL

filgrastim

Packing/Price

4 × 1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Prolia

Prolia soln for inj 60 mg/mL

denosumab

Packing/Price

1 mL x 1's (P18,490.00/pre-filled syringe)

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Vectibix

Vectibix infusion conc 20 mg/mL

panitumumab

Packing/Price

5 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.

Xgeva

Xgeva 120 mg/1.7 mL (70 mg/mL)

denosumab

Packing/Price

1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Distributed by Zuellig

Kanjinti

Kanjinti powd for conc for soln for infusion 150 mg

trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Mvasi

Mvasi infusion conc 100 mg/4 mL

bevacizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Mvasi infusion conc 400 mg/16 mL

bevacizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Neulastim

Neulastim soln for inj 6 mg/0.6 mL

pegfilgrastim

Packing/Price

(pre-filled syringe) 1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Neupogen

Neupogen soln for inj 300 mcg/mL

filgrastim

Packing/Price

4 × 1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Prolia

Prolia soln for inj 60 mg/mL

denosumab

Packing/Price

1 mL x 1's (P18,490.00/pre-filled syringe)

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Vectibix

Vectibix infusion conc 20 mg/mL

panitumumab

Packing/Price

5 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.

Xgeva

Xgeva 120 mg/1.7 mL (70 mg/mL)

denosumab

Packing/Price

1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.